Status:
COMPLETED
Gut Microbiota Transplantation in Systemic Sclerosis
Lead Sponsor:
Oslo University Hospital
Conditions:
Scleroderma, Systemic
Eligibility:
FEMALE
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
Systemic Sclerosis (SSc) is a progressive multi-organ disorder with high disease burden. Life expectancy in SSc is reduced by 25-40 years, mainly due to cardiopulmonary and gastro-intestinal (GI) dise...
Detailed Description
This is a randomized, double blind clinical trial testing intervention by standardized GMT. The study cohort will include 10 SSc patients with GI symptoms. Evaluation of end points is at 16 weeks. The...
Eligibility Criteria
Inclusion
- Fulfillment of the 2013 SSc classification criteria
- Objective GI involvement and provide informed consent.
Exclusion
- Severe organ dysfunction (and risk of procedure related complications
- Recent exposure to antibiotics
Key Trial Info
Start Date :
January 18 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 15 2018
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03444220
Start Date
January 18 2018
End Date
October 15 2018
Last Update
March 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital
Oslo, Norway, 0372